Interpace Biosciences, Inc.
IDXG· OTC
IDXGInterpace Biosciences, Inc.
Filed May 15, 2012 · 10-Q · 45 days after period end · 0001054102-12-000021
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $31.68M | $44.30M |
| Net Income | -$272.00K | -$550.00K |
| EPS Diluted | -$0.02 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Interpace Biosciences, Inc. · CIK 1054102 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 15, 2012 · 45 d after period end
